European Archives - Page 97 of 1344 - European Medical Journal

FTSE 100 hits new high as UK pharma stocks surge

UK pharma and healthcare stocks drive FTSE 100 to a record high, led by AstraZeneca, as trade policy shifts boost investor confidence.

TAVR graph

TAVR Reinterventions on the Rise, Data Shows

TAVR reintervention rates and procedural volumes are climbing, as growing numbers of patients outlive their original implants.

viral hepatitis

Viral Hepatitis Screening and Universal Detection Strategies

Traditionally, most European and Spanish guidelines recommend viral hepatitis screening only in individuals with recognised risk factors or elevated liver enzyme levels.

blood clot

Delayed Diagnosis Drives Mortality in Blood Clot Cases

Delayed diagnosis of blood clots directly increases mortality, highlighting urgent need for faster action in patient care.

Antioxidant Supplements Do Not Boost Male Fertility

Antioxidant Supplements Do Not Boost Male Fertility

Discover a major trial showing antioxidant supplements do not boost male fertility or pregnancy rates, challenging their use in fertility care.

Poor Sleep Accelerates Brain Ageing Through Inflammation

Poor sleep is linked to faster brain ageing, with systemic inflammation playing a partial role, according to new findings from the UK Biobank.

psoriasis

Psoriasis Treatment Failure and Systemic Therapy Guidance

The International Psoriasis Council (IPC) has outlined clear criteria to help clinicians determine when systemic therapy should be prioritised.

Scientists Generate Human Eggs Using Skin Cells

Discover a breakthrough study where scientists turned human skin cells into fertilisable eggs, offering hope for infertility and same-sex couples.

2 Oct 2025

Allergic Rhinitis in Children: The School Environment

Allergens, allergic rhinitis (AR), allergy, allergy-friendly schools, antihistamines, asthma, nasal corticosteroids, non-sedating...

Month in pharma news, explained

Month in pharma news, explained – September 2025

Read this month’s pharma news roundup, featuring AI in healthcare risks, GLP-1 drug trials beyond obesity and Trump’s US tariffs.